Skip to main content
Kent Academic Repository

Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin

Ramage, Walter, Gaiotto, Tiziano, Ball, Christina, Risley, Paul, Carnell, George William, Temperton, Nigel J., Cheung, Chung, Engelhardt, Othmar G., Hufton, Simon (2019) Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin. Antibodies, 8 (1). Article Number 14. E-ISSN 2073-4468. (doi:10.3390/antib8010014) (KAR id:72273)


Influenza B virus (IBV) circulates in the human population and causes considerable disease burden worldwide, each year. Current IBV vaccines can struggle to mount an effective cross-reactive immune response, as strains become mismatched, due to constant antigenic changes. Additional strategies which use monoclonal antibodies, with broad reactivity, are of considerable interest, both, as diagnostics and as immunotherapeutics. Alternatives to conventional monoclonal antibodies, such as single domain antibodies (NanobodiesTM) with well-documented advantages for applications in infectious disease, have been emerging. In this study we have isolated single domain antibodies (sdAbs), specific to IBV, using alpacas immunised with recombinant hemagglutinin (HA) from two representative viruses, B/Florida/04/2006 (B/Yamagata lineage) and B/Brisbane/60/2008 (B/Victoria lineage). Using phage display, we have isolated a panel of single domain antibodies (sdAbs), with both cross-reactive and lineage-specific binding. Several sdAbs recognise whole virus antigens, corresponding to influenza B strains included in vaccines spanning over 20 years, and were capable of neutralising IBV pseudotypes corresponding to prototype strains from both lineages. Lineage-specific sdAbs recognised the head domain, whereas, sdAbs identified as cross-reactive could be classified as either head binding or stem binding. Using yeast display, we were able to correlate lineage specificity with naturally occurring sequence divergence, at residue 122 in the highly variable 120 loop of the HA1 domain. The single domain antibodies described, might have applications in IBV diagnostics, vaccine potency testing and as immunotherapeutics.

Item Type: Article
DOI/Identification number: 10.3390/antib8010014
Subjects: Q Science > QR Microbiology > QR355 Virology
Divisions: Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Nigel Temperton
Date Deposited: 10 Feb 2019 10:19 UTC
Last Modified: 09 Dec 2022 03:24 UTC
Resource URI: (The current URI for this page, for reference purposes)

University of Kent Author Information

Carnell, George William.

Creator's ORCID:
CReDIT Contributor Roles:

Temperton, Nigel J..

Creator's ORCID:
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.